MedPath

Biological Monitoring of Nano Sized Particles in the Airways of Asthmatic Children

Conditions
Asthma
Registration Number
NCT01754948
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Brief Summary

Background Ambient airborne particulate material (PM) is defined according the aerodynamic diameter into coarse, fine, and ultrafine or "nano" sized particles ranging between 2.5-10 µm (coarse), \<2.5 µm (fine), and \<0.1 µm (nano(. Many studies have examined particle effect on respiratory health in children, mainly by environmental monitoring of coarse and fine particles. Biological assessment of individual exposure to nano sized particles in correlation to adverse health effect was not previously studied.

Hypothesis individual exposure to nano sized particles in children is associated with reduction in forced expiratory volume at one second.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • age 6-18 years
  • living in the Tel Aviv area
  • referred to the pulmonology lab for respiratory function evaluation
Exclusion Criteria
  • Exposure to cigarette smoke
  • Respiratory infection in the 4 weeks prior to recruitment and testing

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
spirometry values1 sec

forced expiratory volume at one second

Secondary Outcome Measures
NameTimeMethod
methacholine and adenosine challenge test results1 sec

provocative concentration causing a 20% fall in forced expiratory volume at one second and provocative dose causing a 20% fall in forced expiratory volume at one second

Trial Locations

Locations (1)

Tel Aviv Medical Center

🇮🇱

Tel Aviv, Israel

© Copyright 2025. All Rights Reserved by MedPath